Y-mAbs to Host Key Opinion Leader Webinar on DANYELZA® (naxitamab-gqgk) Frontline and HITS Data in High-Risk Neuroblastoma
Y-mAbs Therapeutics, Inc. (YMAB)
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that it will host a key opinion leader ("KOL") webinar on DANYELZA frontline and HITS data in high-risk neuroblastoma on Thursday, September 23, 2021 at 12 p.m. ET. This webinar will feature presentations from KOLs Jaume Mora, M.D., Ph.D., SJD Barcelona Children's Hospital, and Shakeel Modak, M.D., MRCP, Memorial Sloan Kettering. Additionally, Thomas Gad, Chairman, Founder, and President at Y-mAbs, will provide a brief introduction followed by presentations from Steen Lisby, M.D., DMSc, SVP, Chief Scientific Officer at Y-mAbs, and Claus J. Moller San-Pedro, M.D., Ph.D., Chief Executive Officer at Y-mAbs. Dr. Mora will present frontline data for DANYELZA in High-Risk NeuroblastomaDr. Moda
Show less
Read more
Impact Snapshot
Event Time:
YMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
YMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
YMAB alerts
High impacting Y-mAbs Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
YMAB
News
- Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024GlobeNewswire
- Y-mAbs to Present at 2024 ASCO Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Y-mAbs to Present at 2024 ASCO Annual MeetingGlobeNewswire
- New Strong Buy Stocks for April 19th [Yahoo! Finance]Yahoo! Finance
- Y-mAbs Therapeutics (NASDAQ:YMAB) rises 9.6% this week, taking one-year gains to 161% [Yahoo! Finance]Yahoo! Finance
YMAB
Earnings
- 2/29/24 - Beat
YMAB
Sec Filings
- 4/8/24 - Form SC
- 3/14/24 - Form 4
- 3/14/24 - Form 8-K
- YMAB's page on the SEC website